Ad is loading...
GMNCX
Price
$11.60
Change
-$0.05 (-0.43%)
Updated
Nov 15 closing price
RSLEX
Price
$68.12
Change
-$0.84 (-1.22%)
Updated
Nov 15 closing price
Ad is loading...

GMNCX vs RSLEX

Header iconGMNCX vs RSLEX Comparison
Open Charts GMNCX vs RSLEXBanner chart's image
Gabelli Global Mini Mites C
Price$11.60
Change-$0.05 (-0.43%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World R4
Price$68.12
Change-$0.84 (-1.22%)
VolumeN/A
CapitalizationN/A
GMNCX vs RSLEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GMNCX vs. RSLEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMNCX is a Sell and RSLEX is a Buy.

FUNDAMENTALS
Fundamentals
RSLEX has more cash in the bank: 74.7B vs. GMNCX (11.9M). RSLEX pays higher dividends than GMNCX: RSLEX (0.65) vs GMNCX (0.53). GMNCX was incepted earlier than RSLEX: GMNCX (6 years) vs RSLEX (22 years). GMNCX is a more actively managed with annual turnover of: 42.00 vs. RSLEX (29.00). RSLEX has a lower initial minimum investment than GMNCX: RSLEX (250) vs GMNCX (10000). RSLEX annual gain was more profitable for investors over the last year : 16.00 vs. GMNCX (9.61). GMNCX return over 5 years is better than : 26.72 vs. RSLEX (18.89).
GMNCXRSLEXGMNCX / RSLEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years22 years-
Gain YTD6.9123.747185%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets11.9M74.7B0%
Annual Yield % from dividends0.530.6581%
Returns for 1 year9.6116.0060%
Returns for 3 years-10.97-25.8642%
Returns for 5 years26.7218.89141%
Returns for 10 yearsN/A39.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACVA20.720.70
+3.50%
ACV Auctions
FBMS36.370.12
+0.33%
First Bancshares
HFFG3.42-0.04
-1.16%
HF Foods Group
UTHR363.25-23.02
-5.96%
United Therapeutics Corp
NLSP3.13-0.21
-6.29%
Nls Pharmaceutics Ltd